Research demonstrates potential of local siRNA delivery as COVID antiviral therapy in the lung - News-Medical.Net

Scientists develop a formulation for the pulmonary administration of siRNA. The aim was to suppress the replication of SARS-CoV-2.

Small interfering ribonucleic acid (siRNA)-based therapies have shown promise in fighting viral infections by targeting a specific region of the viral genome and downregulating viral replication effi… [+5490 chars]

full article...